Opaleye Management Inc. Aligos Therapeutics, Inc. Put Options Transaction History
Opaleye Management Inc.
- $548 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALGS
# of Institutions
32Shares Held
37.7MCall Options Held
1.4KPut Options Held
300-
Hhlr Advisors, Ltd. Grand Cayman, E93.12MShares$59 Million0.03% of portfolio
-
Tang Capital Management LLC San Diego, CA1.65MShares$31.2 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il277KShares$5.24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY227KShares$4.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny29.9KShares$564,7500.0% of portfolio
About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $751M
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...